Predicting success of desensitization after pegaspargase allergy
Author:
Affiliation:
1. St. Jude Children’s Research Hospital, Memphis, TN
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/135/1/71/1550394/bloodbld2019003407.pdf
Reference15 articles.
1. PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol;Henriksen;Pediatr Blood Cancer,2015
2. Clinical characteristics of intravenous PEG-asparaginase hypersensitivity reactions in patients undergoing treatment for acute lymphoblastic leukemia;Browne;J Pediatr Oncol Nurs,2018
3. Antibodies predict pegaspargase allergic reactions and failure of rechallenge;Liu;J Clin Oncol,2019
4. A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403;Stock;Blood,2019
5. Universal premedication and therapeutic drug monitoring for asparaginase-based therapy prevents infusion-associated acute adverse events and drug substitutions;Cooper;Pediatr Blood Cancer,2019
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Multiple reactions during desensitization and predicting decreased efficacy of pegaspargase chemotherapy;Annals of Allergy, Asthma & Immunology;2024-08
2. The correlation of asparaginase enzyme activity levels after PEG‐asparaginase administration with clinical characteristics and adverse effects in Chinese paediatric patients with acute lymphoblastic leukaemia;British Journal of Haematology;2024-06-27
3. Comment on: Desensitization using PEGasparaginase in the era of commercially available Erwinia: A single‐institution report on efficacy, cost, and resource utilization;Pediatric Blood & Cancer;2024-03-03
4. Desensitization using pegaspargase in the era of commercially available Erwinia: A single‐institution report on efficacy, cost, and resource utilization;Pediatric Blood & Cancer;2024-02-04
5. Attempted desensitization to calaspargase pegol: a familiar approach to a new problem;Leukemia & Lymphoma;2023-11-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3